APA Citatie

Keystone, E. C., Taylor, P. C., Tanaka, Y., Gaich, C., DeLozier, A. M., Dudek, A., . . . Weinblatt, M. E. (2017). Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: Secondary analyses from the RA-BEAM study. Ann Rheum Dis.

Chicago Style citaat

Keystone, Edward C., et al. "Patient-reported Outcomes From a Phase 3 Study of Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: Secondary Analyses From the RA-BEAM Study." Ann Rheum Dis 2017.

MLA citatie

Keystone, Edward C., et al. "Patient-reported Outcomes From a Phase 3 Study of Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: Secondary Analyses From the RA-BEAM Study." Ann Rheum Dis 2017.